Clinical trial
Humoral and Cell-mediated Immune Response to Influenza Vaccine in Kidney Tranpslant Recipients.
NCT00677547 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Humoral and Cell-mediated Immune Response to Influenza Vaccine in Kidney Tranpslant Recipients.
- Lead sponsor
- University of Alberta
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- June 30, 2010
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant